PBYI

Puma Biotechnology, Inc. $9.12 1M +2.5% 3M +26.1% YTD +58.1% as of 2026-09-11
+Watchlist

↑↓ next ticker · ⌘+↑↓ or scroll to zoom · ←→ pan · 0 reset

▲ buy   ▼ sell  ·  size ≈ trade size  · earnings ● beat ● miss  ·  ring ◯ before open ◯ after close  · ─ moving averages · click the buttons above to hide them

Model view — historical tendencies for the days ahead, not a forecast
Next 1 day
-0.3%
Next 1 week
+0.0%
Next 1 month
-0.8%
Seasonality
Weak window historically
Next 30 days (to Oct 14): -12.7% median, 23% of the last 13 years finished up.
20-year seasonality chart →
Mean reversion
Neutral — RSI(2) at 32
RSI(2) under 15 is oversold (this name has historically bounced); over 85 is overbought. Its dip-buy edge in history is -0.23%/day.
Mean-reversion stats →
1-month breakdown — Market · β 0.56 -0.1% · Seasonal tilt -0.7%
$3M/day volume 59% volatility +101% 1-year
52-week range · 89% of the way up · -6% from the high
$4.30$9.74

Congressional trades in PBYI Full tracker →

2 members · 4 buys / 3 sells · $35K–$175K disclosed · latest filing Apr 27, 2020.

BUY DS Donna Shalala · traded Jan 23, 2019 $1K–$15K
SELL DS Donna Shalala · traded May 15, 2019 $1K–$15K
BUY NR Nick J. Rahall · traded Sep 10, 2014 $1K–$15K
SELL NR Nick J. Rahall · traded Sep 26, 2014 $1K–$15K
SELL NR Nick J. Rahall · traded Jul 23, 2014 $15K–$50K
BUY NR Nick J. Rahall · traded Jul 24, 2014 $15K–$50K
BUY NR Nick J. Rahall · traded Jul 30, 2014 $1K–$15K

Earnings Full history →

Next report 2026-11-05 (Thursday, after close, in 52 days) · EPS est. 0.19.

1-day std dev
15.4%
Finished up
50%
Biggest pop
+40.0%
Biggest drop
-48.0%

Standard deviation of the close-to-close move over the last 58 reports. History, not a forecast.

Data from the U.S. House Clerk and FINRA, plus end-of-day prices. Not investment advice.